Baby KJ's Medical Team to Seek FDA Approval for Gene Editing Clinical Trial
Baby KJ's doctors plan to ask the FDA this winter to approve a clinical trial for a pioneering gene editing approach.
The trial would be open to patients with seven different urea cycle disorders, according to Baby KJ's medical team.
"This is what we thought we would never get,"
Kyle Muldoon, Baby KJ's father, expressed his emotions as he watched a football game with his son, highlighting the significance of ordinary moments for his family.
Author's summary: Baby KJ's medical team seeks FDA approval for gene editing trial.
More News
- Nicki Minaj rages at gay fan who criticized her for thanking Donald Trump - LGBTQ Nation
- Patriots Avoided a Big Mistake After Jakobi Meyers Trade News
- Toronto Tempo Wins the Sandy Brondello Sweepstakes
- Mexican Authorities Suspect That Mayor Was Killed By The Jalisco Cartel: Report
- Integration of Health Services Vital for Sustaining HIV Gains | Science Africa
- Inside Selling Sunset Star Bre Tiesi's Lawsuit
- All proceedings to be moved out of Pikeville federal courthouse - Mountain Top Media
- "Moore keeps redistricting push alive in Maryland amid national map fights" #ELB
- High wind Warning Issued for Our Area - Sonoma Valley Sun
- Defense attorney objects to any further delay in Amber Spradlin trial - Mountain Top Media